Men could soon be offered quick MRI scans lasting under 15 minutes to detect prostate cancer earlier, under new recommendations from international experts.

We’re prostate cancer experts. Here are the benefits of quick and targeted MRI scans - Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prosta ...

Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026.

I was able to book my scan super easily with only a six-day wait. The whole process was super easy and had my scan results back to me within two days.' ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...

Lord Brady discovered he had the disease after taking a PSA blood test that indicates cancer risk. This was followed by two ...

The Department of Health has issued a statement on prostate cancer screening following a parliamentary petition.

Add Yahoo as a preferred source to see more of our stories on Google. While many people are familiar with mammograms and smear tests, prostate screening is talked about far less. To shed light on this ...

'The exact cause of death is not known yet and will be determined after completion of the enquiry' Kindly note that this image has been posted for representational purposes only. Photograph: Courtesy ...

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...